# INTERVIEW: SkinBiotherapeutics Skinbiotix Positive Results in Cream

- Link: https://www.directorstalkinterviews.com/interview-skinbiotherapeutics-skinbiotix-positive-results-cream/412749475
- Published: 2018-04-18T07:20:07+01:00
- Author: Giles Arbor

**SkinBioTherapeutics Plc** (LON:SBTX) CEO Dr. Cath O’Neill talks to DirectorsTalk
about the positive results skinbiotix shows in cream formulation. Cath explains 
the results, the significance, how the technology works, stability testing, the 
next major milestones and readiness to commercialise its cosmetic product in 2018.

SkinBioTherapeutics is a life science company focused on skin health. The Company’s
proprietary platform technology, SkinBiotix®, is based upon discoveries made by 
CEO Dr. Catherine O’Neill and Professor Andrew McBain.

The platform platform applies research discoveries made on the activities of lysates
derived from probiotic bacteria when applied to the skin. The Company has shown 
that the SkinBiotix® platform can improve the barrier effect of skin models, protect
skin models from infection and repair skin models. Proof of principle studies have
shown that the SkinBiotix® platform has beneficial attributes applicable to each
of these areas. The company received seed funding from the Tech Transfer office 
of the University of Manchester for the discovery of SkinBiotix®. The platform was
subsequently spun out of the University of Manchester in March 2016 and was funded
by OptiBiotix Health Plc (LON:OPTI).

Share on: